Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Applied Drug Policy Research Experiences

U.S. Office of National Drug Control Policy·United States of America

Applied Drug Policy Research Experiences

Closes 9/6/2026$1 – $100kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Office of National Drug Control Policy is seeking applications for the Applied Drug Policy Research Experiences project. This project aims to establish applied drug policy research experiences for graduate students and recent post-graduates to conduct rigorous research studies and data analyses to support the National Drug Control Strategy. The research will investigate dynamic shifts in, and associations between, illicit drug supply, drug use, and their associated consequences, to help public health and public safety officials anticipate new drug outbreaks and prepare faster and more effective responses to protect the American public. • The project will focus on supporting the National Drug Control Strategy. • The research will investigate dynamic shifts in, and associations between, illicit drug supply, drug use, and their associated consequences. • The project aims to help public health and public safety officials anticipate new drug outbreaks and prepare faster and more effective responses. • The application deadline is September 6, 2026. • The award ceiling for this project is $100,000.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Madeleine Steppel(Policy Analyst)

[email protected]

(202) 881-7902

Key dates

Opened
8/6/2026
Closes
9/6/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541720
Solicitation №
RD-AL-RDAAL-26-001

Budget estimate

$1 – $100,000

The budget for this opportunity is estimated to be around $100,000, as specified in the document. This estimate is based on the award ceiling mentioned in the document. The actual budget may vary depending on the specific requirements and needs of the project. Factors that may influence the budget include the complexity of the research, the number of personnel involved, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 69%

Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)

Closes 9/9/2027Opened 9/20/2024

U.S. National Institutes of Health·United States of America

65% match

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

64% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. National Institutes of Health·United States of America

64% match

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029Opened 1/26/2026

U.S. Food and Drug Administration·United States of America

64% match

Center for Research on Complex Generics (U18) Clinical Trials Optional

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

63% match

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

63% match

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Closes 3/5/2027Opened 1/17/2024

U.S. Food and Drug Administration·United States of America

62% match

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

62% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

62% match

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

62% match

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closes 11/18/2027Opened 11/20/2024

U.S. National Institutes of Health·United States of America

61% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

U.S. National Institutes of Health·United States of America

61% match

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

Closes 3/16/2029Opened 9/10/2025

U.S. Food and Drug Administration·United States of America

61% match

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. Food and Drug Administration·United States of America

61% match

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

61% match

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

61% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

61% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

61% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. Food and Drug Administration·United States of America

61% match

Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

61% match

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Closes 10/27/2027Opened 5/11/2021

U.S. Food and Drug Administration·United States of America

60% match

Collaborations to Enhance Drug Development and Regulatory Science

Rolling / TBD closeOpened 11/30/2023

U.S. National Institutes of Health·United States of America

60% match

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

Closes 11/13/2026Opened 1/3/2024

U.S. National Institutes of Health·United States of America

60% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

60% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025